Medirom Healthcare Technologies Inc. (MRM) Cash & Current Investments (2019 - 2025)

Medirom Healthcare Technologies' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $268282.2 for Q2 2025.

• In Q2 2025, Cash & Current Investments fell 71.13% year-over-year to $268282.2; the TTM figure through Jun 2025 stood at $268282.2 (down 71.13% YoY), while the FY2024 annual figure was $2.2 million, up 133.79% from the prior year.
• Cash & Current Investments for Q2 2025 stood at $268282.2, down from $2.2 million in the prior quarter.
• The five-year high for Cash & Current Investments was $4.5 million in Q4 2022, with the low at $268282.2 in Q2 2025.
• The 5-year median for Cash & Current Investments is $929204.2 (2024), against an average of $1.9 million.
• The sharpest annual moves came in 2021 and 2023: Cash & Current Investments surged 1022.47% in 2021, then slumped 79.91% in 2023.
• Medirom Healthcare Technologies' Cash & Current Investments stood at $3.5 million in 2021, then increased by 28.03% to $4.5 million in 2022, then plunged by 79.91% to $898754.4 in 2023, then surged by 145.58% to $2.2 million in 2024, then tumbled by 87.85% to $268282.2 in 2025.
• Business Quant data shows MRM's Cash & Current Investments at $268282.2 in Q2 2025, $2.2 million in Q4 2024, and $929204.2 in Q2 2024.